Olfactory impairment predicts brain atrophy in Parkinson's disease. 2009

Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
Department of Neurosurgery, University Hospital, University of Basel, CH-4031 Basel, Switzerland.

Olfactory dysfunction is a frequent nonmotor symptom in idiopathic Parkinson's disease (PD) and may be considered as an early clinical feature of the disease preceding motor symptoms by years. According to recent neuropathological staging concepts, impaired olfaction is assumed to indicate an early pathological process and might be associated with structural changes in the brain. A morphometric analysis of magnetic resonance images [voxel-based morphometry (VBM)] was used to investigate gray matter atrophy related to psychophysically measured scores of olfactory function in early PD patients (n = 15, median Hoehn and Yahr stage 1.5), moderately advanced PD patients (n = 12, median Hoehn and Yahr stage 2.5), and age-matched healthy controls (n = 17). In PD patients, but not in controls, cortical atrophy in olfactory-related brain regions correlated specifically with olfactory dysfunction. Positive correlations between olfactory performance and gray matter volume were observed in the right piriform cortex in early PD patients and in the right amygdala in moderately advanced patients. The results provided first evidence that olfactory dysfunction in PD is related to atrophy in olfactory-eloquent regions of the limbic and paralimbic cortex. In addition, olfactory-correlated atrophy in these brain regions is consistent with the assumption that olfactory impairment as an early symptom of PD is likely to be associated with extranigral pathology.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
April 2016, Parkinsonism & related disorders,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
July 1983, Neurology,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
January 2012, Brain : a journal of neurology,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
February 2023, Human brain mapping,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
August 2014, Movement disorders : official journal of the Movement Disorder Society,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
January 2020, CNS neuroscience & therapeutics,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
July 1985, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
May 2013, Journal of neurology, neurosurgery, and psychiatry,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
March 2001, Proceedings of the National Academy of Sciences of the United States of America,
Elise Wattendorf, and Antje Welge-Lüssen, and Klaus Fiedler, and Deniz Bilecen, and Markus Wolfensberger, and Peter Fuhr, and Thomas Hummel, and Birgit Westermann
January 2020, Frontiers in neuroscience,
Copied contents to your clipboard!